期刊文献+

促脑血管疾病危险因素与帕金森病相关性研究 被引量:3

Relationship between Parkinson's disease and risk factors of cerebrovascular disease
下载PDF
导出
摘要 目的:探讨促脑血管疾病的一些常见危险因素与帕金森病(Parkinson's disease,PD)之间的关系。方法:对在重庆医科大学附属第一医院就诊的PD患者及健康体检者抽血检测血糖、低密度脂蛋白胆固醇(Low density lipoprotein cholesterol,LDL-C)及同型半胱氨酸(Homocysteic acid,Hcy),同时行颈动脉彩超了解颈总动脉内膜中层厚度(Intima-media thickness of carotid artery,IMT),对PD患者进行帕金森病统一评定量表(Unified Parkinson's disease rating scale,UPDRS)评分。对PD组和对照组检查结果进行统计学分析,并将可能与PD发病有关的因素纳入相关分析。结果:PD组血糖水平高于对照组(P<0.05);Hcy水平高于对照组(P<0.01);PD组LDL-C水平低于对照组(P<0.05);IMT值小于对照组(P<0.001)。Spearman相关分析显示Hcy与PD发病呈正相关,LDL-C、IMT与PD发病呈负相关,血糖与PD发病无明显相关性。结论:本实验结果提示高Hcy是PD发病的危险因素;实验证实PD病人LDL-C、IMT明显低于对照组,提示患动脉粥样硬化的几率相对较小。 Objective:To investigate the relationship between some common risk factors of the cerebralvascular diseases and PD.Methods:Case-control study was carried out.Blood glucose,low density lipoprotein cholesterol(LDL-C)and homocysteic acid(Hcy) levels were detected by routine methods.The intima-media thickness(IMT)of carotid artery was measured by color Doppler ultrasound.The PD patients were graded by Unified Parkinson's Disease Rating Scale(UPDRS).Results:The blood glucose and Hcy in PD patients were higher than that in control group,and the LDL-C,IMT of carotid artery in PD were lower than that in control group.The Hcy was positively related to risk of PD,while IMT of carotid artery and LDL-C were negatively related to risk of PD by Spearman analysis.Conclusion:The Hcy level is a risk factor of PD.The LDL-C and IMT of carotid artery in PD patients were lower than that in control group,which suggests that the probability of PD patients who suffer from atherosclerosis is small.
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2010年第4期561-563,共3页 Journal of Chongqing Medical University
关键词 帕金森病 颈动脉内膜中层厚度 血糖 低密度脂蛋白胆固醇 同型半胱氨酸 相关性 Parkinson's disease IMT Blood glucose LDL-C Hcy Relationship
  • 相关文献

参考文献14

  • 1Nanhoe-Mahabier W,de Laat K F,Visser J E,et al.Parkinson disease and comorbid cerebrovasculardisease[J].Nat Rev Neurol,2009,5(10):533-541. 被引量:1
  • 2张振馨.帕金森病的诊断[J].中华神经科杂志,2006,39(6):408-409. 被引量:617
  • 3O'Suilleabhain P E,Sung V,Hernandez C,et al.Elevated plasma ho-mocysteine level in patients with Parkinson disease:motor,affective,and cognitive associations[J].Arch Neural,2004,61 (6):865-868. 被引量:1
  • 4史蕙青,张博爱,贾延劼,陈烈冉.血浆同型半胱氨酸的水平与帕金森病之间的关系[J].中国实用神经疾病杂志,2006,9(6):48-49. 被引量:9
  • 5Zoccolella S,Dell' aquila C,Specchio LM,et al.Elevatd Homocys-teine Levels in Parkinson' s Disease:Is there Anything Besides L-Dope Treatment[J].Curr Med Chem,2009,24(8):1034-1037. 被引量:1
  • 6Yuan R Y,Sheu JJ,Yu J M,et al.Methylenetetrahydrofolate reduc-tase palymorphisms an plasma homocysteine in levodopa-treated and non-treated Parkinson's disease patients[J].J Neurol Sci,2009,287(1-2):64-68. 被引量:1
  • 7Hu G,Jousilahti P,Bidel S,et al.Type 2 diabetes and the risk of Parkinson' s disease[J].Diabetes Care,2007,30(4):842-847. 被引量:1
  • 8Bedrood S,Jayasinghe S,Sieburth D,et al.Annexin A5 directly interacts with amyloidogenic proteins and reduces their toxiciry[J].Biochemistry,2009,48(44):10568-10576. 被引量:1
  • 9Huang X,Abbott R D,Petrovitch H,et al.Low LDL cholesterol and increased risk of Parkinson's disease:prospective results from Honolulu-Asia Aging Study[J].Mov Disord,2008,23(7):1013-1018. 被引量:1
  • 10Huang X,Chen H,Miller W C,et al.Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease[J].Mov Disord,2007,22(3):377-381. 被引量:1

二级参考文献27

  • 1史蕙青,张博爱,贾延劼,陈烈冉.血浆同型半胱氨酸的水平与帕金森病之间的关系[J].中国实用神经疾病杂志,2006,9(6):48-49. 被引量:9
  • 2[1]Lang D,Kredan MB,Moat SJ,et al.Homocysteine induced inhibition of endothelium dependent relaxation in relaxation in rabbit aorta:role for superoxide anions[J].Arterioscler Thromb Vasc boil,2000,20:422 ~ 427 被引量:1
  • 3[2]Outinenen PA,Sood SK,Pfeier SI,et al.Homocysteine-induced endoplasmic peticulum stress and growth arrest leads to specific changes in gene expression in human vascular endothelial cells[J].Blood,1999,94:959 ~967 被引量:1
  • 4[3]Serhat Ozkan,Omer Colak,Ceyhan Kutlu,et al.Plasma homocysteine levels in pergolide treated parkinson disease patients[J].Clin Neuropharmacol,2004,27(4):163~ 165 被引量:1
  • 5[4]Blandini F,Fancellu R,Martignoni E,et al.Plasma homocysteine and L-dopa metabolism in patients with Parkinson disease[J].Clin Chem,2001,47:1102~1104 被引量:1
  • 6[5]JW Miller,J Selhub,MR Nadeau,et al.Effect of L-dopa on plasma homocysteine in PD patients relationship to B-vitamin status[J].Neurology,2003,60:1125~1129 被引量:1
  • 7[2]Pericak-vance MA,Haines JL.Genetic susceptibility to Alzheimer disease[J].Trends Genet,1995,11:504-508. 被引量:1
  • 8[3]National Institute of Aging/Alzheimer Association Working Group,Apolipoprotein E genotyping in Alzheimer's disease[J].Lancet,1996,347:1091-1095. 被引量:1
  • 9[4]Elbaz A,Bower JH,Maraganore DM,.et al.Risk tables for Parkinsonism and Parkinson's disease[J].J Clin Epidemiol,2002,55:25-31. 被引量:1
  • 10[5]Zareparsi S,Camicioli R,Sexton G,et al.Age of onset of Parkinson disease and apolipoprotein E genotypes[J].Am J Med Genet,2002,111:459-469. 被引量:1

共引文献627

同被引文献24

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部